top of page
topic
May 22, 2025
Vitalive and A2 Healthcare Announce to Streamline Survival Follow-Up and Accelerate Digital Transformation in Oncology Clinical Trials
Vitalive Inc. (Head Office: Minato-ku, Tokyo; CEO: Makoto Inoue; hereinafter "Vitalive") and A2 Healthcare Corporation (Headquarter: Bunkyo-ku, Tokyo; President and CEO: Hitoshi Kamiya; hereinafter "A2") have entered into a partnership to promote the use of “VitaliveOS,” a system developed by Vitalive, with the aim of improving the efficiency of survival follow-up in oncology clinical trials.
bottom of page